Evanston Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-3,981
Closed -$459K 63
2016
Q4
$459K Buy
3,981
+6
+0.2% +$693 0.14% 50
2016
Q3
$470K Buy
3,975
+5
+0.1% +$607 0.15% 50
2016
Q2
$482K Sell
3,970
-44
-1% -$5K 0.16% 50
2016
Q1
$434K Buy
4,014
+5
+0.1% +$518 0.14% 50
2015
Q4
$412K Buy
4,009
+55
+1% +$5.53K 0.14% 49
2015
Q3
$369K Sell
3,954
-94
-2% -$9.09K 0.12% 55
2015
Q2
$394K Buy
4,048
+106
+3% +$10.6K 0.13% 55
2015
Q1
$397K Sell
3,942
-138
-3% -$14K 0.13% 55
2014
Q4
$427K Buy
4,080
+148
+4% +$15.6K 0.15% 54
2014
Q3
$419K Buy
3,932
+5
+0.1% +$519 0.14% 57
2014
Q2
$411K Buy
3,927
+5
+0.1% +$505 0.14% 57
2014
Q1
$385K Buy
3,922
+9
+0.2% +$834 0.14% 57
2013
Q4
$358K Buy
+3,913
New +$361K 0.13% 55

Other funds holding JNJ

Evanston Advisors's JNJ Position: Q1 2017 in Review

Evanston Advisors sold out of Johnson & Johnson (JNJ) in Q1 2017, closing a stake of 3,981 shares — an estimated $459K sold.

Evanston Advisors first reported a position in JNJ in Q4 2013 and held it in 13 quarters. The position peaked at $482K in Q2 2016. 2,349 funds tracked by Wall St. Rank hold JNJ as of Q1 2017.

  • Evanston Advisors reported no remaining Johnson & Johnson position as of Q1 2017 after selling out during the quarter.
  • Evanston Advisors sold 3,981 Johnson & Johnson shares in Q1 2017, an estimated $459K.
  • Evanston Advisors first reported a position in Johnson & Johnson in Q4 2013 and held it in 13 quarters.
  • Evanston Advisors's Johnson & Johnson position peaked at $482K in Q2 2016.
  • 2,349 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2017.

Based on Evanston Advisors's 13F filing for Q1 2017, filed 5 May 2017.